Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04631406 · ClinicalTrials.gov registry record · Phase 1

A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)

A Phase 1 study of Ischemic Stroke, sponsored by Gary Steinberg, MD, PhD.

Active
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT04631406 is a Phase 1 study of Ischemic Stroke that is active but no longer recruiting, run by Gary Steinberg, MD, PhD. The registered enrollment target is 30 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04631406, a Phase 1 study of Ischemic Stroke, is active but no longer recruiting, sponsored by Gary Steinberg, MD, PhD.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Evaluation of the safety and tolerability of escalating doses of NR1 administered intracerebrally at a single time-point post-injury to subjects with chronic ISS with or without cortical stroke.

Conditions Studied

Ischemic Stroke

Interventions

  • BIOLOGICAL Neural Stem Cells

Study Locations (1)

California

  • Stanford Health Center - Stanford

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-01-04
Est. Completion 2029-08-31
Phase Phase 1

Sponsor

Gary Steinberg, MD, PhD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04631406

The ClinicalTrials.gov registry entry for NCT04631406 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (98% lower). The listed sponsor is Gary Steinberg, MD, PhD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Neural Stem Cells is the first listed.

NCT04631406 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04631406 about?

NCT04631406 is a clinical study titled "A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)". Evaluation of the safety and tolerability of escalating doses of NR1 administered intracerebrally at a single time-point post-injury to subjects with chronic ISS with or without cortical stroke.

What is the current status of trial NCT04631406?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2021-01-04. Estimated completion is 2029-08-31.

What conditions does trial NCT04631406 study?

This clinical trial studies the following conditions: Ischemic Stroke.

What interventions are being tested in trial NCT04631406?

The interventions under investigation include: Neural Stem Cells (BIOLOGICAL).

Who is sponsoring clinical trial NCT04631406?

This trial is sponsored by Gary Steinberg, MD, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04631406 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ischemic Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ischemic Stroke

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.